Growth factors during HCV therapy may be “cost-effective”, but are they “effective”?

Authors

  • Andrew J. Muir M.D., M.H.S.,

    1. Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Center, Durham, NC
    Search for more papers by this author
  • John G. McHutchison M.D.

    Corresponding author
    1. Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Center, Durham, NC
    • Duke Clinical Research Institute, P.O. Box 17969, Durham, NC 27715
    Search for more papers by this author
    • fax: 919-668-7164


  • See Article on Page 1598.

  • Potential conflict of interest: Dr. McHutchison and Dr. Muir are consultants for, are on the speakers' bureau of, and received grants from Schering Plough. They received grants from Roche, GlaxoSmithKline, and Pfizer.

Ancillary